Arrowgrass Capital Partners (US)’s Arcturus Therapeutics ARCT Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-12,266	Closed	-$1.56M	–	232
2014 Q1	$1.56M	Sell	12,266 -536	-4%	-$79.4K	0.07%	139
2013 Q4	$1.61M	Buy	+12,802	New	+$1.61M	0.1%	127
2013 Q3	–	Sell	-26,292	Closed	-$1.26M	–	178
2013 Q2	$1.26M	Buy	+26,292	New	+$1.29M	0.18%	79

Other funds holding ARCT

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return

Verition Fund Management

Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return